Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases
- 1 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 188 (5) , 1726-1731
Abstract
The detection of prostate cancer relies primarily on abnormal digital rectal examination or increased serum prostate specific antigen concentration. However, low positive predictive values result in many men with increased prostate specific antigen and/or suspicious digital rectal examination having a negative biopsy. We investigated the value of the PCA3 (prostate cancer gene 3) urine test in predicting the likelihood of diagnosis of cancer before biopsy. We performed a prospective, community based clinical trial to evaluate PCA3 score before any biopsy. This trial was conducted at 50 urology practices in the United States. Samples were obtained from 1,962 men with increased serum prostate specific antigen (greater than 2.5 ng/ml) and/or abnormal digital rectal examination before transrectal prostate needle biopsy. Study samples (urinary PCA3 and biopsies) were processed and analyzed by a central laboratory. Sensitivity-specificity analyses were conducted. A total of 1,913 urine samples (97.5%) were adequate for PCA3 testing. Of 802 cases diagnosed with prostate cancer 222 had high grade prostatic intraepithelial neoplasia or atypical small acinar proliferation and were suspicious for cancer, whereas 889 cases were benign. The traditional PCA3 cutoff of 35 reduced the number of false-positives from 1,089 to 249, a 77.1% reduction. However, false-negatives (missed cancers) increased significantly from 17 to 413, an increase of more than 2,300%. Lowering the PCA3 cutoff to 10 reduced the number of false-positives 35.4% and false-negatives only increased 5.6%. Urinary PCA3 testing in conjunction with prostate specific antigen has the potential to significantly decrease the number of unnecessary prostate biopsies.Keywords
This publication has 22 references indexed in Scilit:
- Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy DecisionsJournal of Urology, 2011
- PCA3: From basic molecular science to the clinical labCancer Letters, 2011
- A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancerProstate Cancer and Prostatic Diseases, 2010
- The lottery of conventional prostate biopsyNature Reviews Urology, 2009
- Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancerBJU International, 2008
- Quality of life after surgery, external beam irradiation, or brachytherapy for early‐stage prostate cancerCancer, 2007
- APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate CancerClinical Chemistry, 2006
- PROSTATE CANCER DETECTION WITH OFFICE BASED SATURATION BIOPSY IN A REPEAT BIOPSY POPULATIONJournal of Urology, 2004
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Quality of Life after Radical Prostatectomy or Watchful WaitingNew England Journal of Medicine, 2002